Skip to content

Correlation between global atherosclerosis level and recurrence of cardiovascular events in patients with symptomatic intracranial and extracranial atherosclerotic stenosis

Correlation between global atherosclerosis level and recurrence of cardiovascular events in patients with symptomatic intracranial and extracranial atherosclerotic stenosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021688
Enrollment
Unknown
Registered
2019-03-05
Start date
2017-07-01
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial atherosclerotic stenosis

Interventions

ICAS:None

Sponsors

Xuanwu Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-80 years; 2. Auxiliary examinations (such as carotid ultrasound, TCD, cranial CTA or MRA) suggest moderate to severe stenosis in MCA (50-99%); 3. Two risk factors for atherosclerosis; 4. Informed consent of patients and their families; 5. (1) Symptomatic intracranial artery stenosis: The first acute ischemic stroke within 14 days occurred in MCA blood supply area confirmed by magnetic resonance DWI; (2) Asymptomatic intracranial artery stenosis: no history of ischemic stroke in the past, or no history of ischemic stroke in MCA blood supply area.

Exclusion criteria

Exclusion criteria: 1. Patients with arrhythmia and other causes who can not complete cardio-cerebral combined CTA examination; 2. Vascular examination revealed moderate or more stenosis or unstable plaque in the lateral extracranial artery of the responsible vessel; 3. The presence of PFO, atrial fibrillation, connective tissue disease, tumors and other patients prone to non-atherosclerotic stroke; 4. Head CT or MRI showed hemorrhage and other lesions (vascular malformations, tumors, brain abscesses); 5. Past history of gastrointestinal ulcer, can not use aspirin and clopidogrel dual anti-platelet aggregation therapy; 6. Liver and kidney function decreased (ALT, AST >3 folders than normal level or creatinine F > 1.5 mg/dl) or CK increased (> 10 folders of normal level); 7. Anaphylaxis or intolerance of aspirin, clopidogrel and statins; 8. Middle cerebral artery occlusion or stenting.

Design outcomes

Primary

MeasureTime frame
Cardiovascular events;Global atherosclerotic plaque burden;

Secondary

MeasureTime frame
Blood biochemical index;calcium score;Degree of vascular stenosis;

Countries

China

Contacts

Public ContactGuo Xiuhai

Xuanwu Hospital, Capital Medical University

guoxhxuan@126.com+86 18810285127

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026